88.4%
National Commission for Science and TechnologyMinistry of HealthNIH Office for Human Research ProtectionsUniversity of MarylandUniversity of Maryland Medical CenterAIC Kijabe Hospitalsolid tumorshematological malignanciesAKUHNChimeric antigen receptor (CAR) T-cell therapy+1 more
… (KH IERC-02718/2019). A research license was obtained from the National Commission for Science and Technology (NACOSTI/P/24/33420) and a material transfer permit obtained fr…